(Q39679501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Niklas K. Björkström

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Tolga Sutlu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Hayrettin Güven

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Lisbeth Barkholt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Reka Conrad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Mari Gilljam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Birgitta Stellan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Birger Christensson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Gunnar Söderdahl

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Kerstin Cederlund

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Eva Kimby

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Johan Aschan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Olle Ringdén

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Hans-Gustaf Ljunggren

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Sirac Dilber

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

753-764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636021%20AND%20SRC:MED&resulttype=core&format=json

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

7 February 2020

cites work

1 reference

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.

21 January 2018

1 reference

Cancer immunotherapy: is there real progress at last?

21 January 2018

1 reference

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

21 January 2018

1 reference

Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans

21 January 2018

1 reference

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

21 January 2018

1 reference

Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma

21 January 2018

1 reference

Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.

21 January 2018

1 reference

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

21 January 2018

1 reference

Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer

21 January 2018

1 reference

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

21 January 2018

1 reference

Ex vivo expansion of natural killer cells for clinical applications

21 January 2018

1 reference

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

21 January 2018

1 reference

Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy.

21 January 2018

1 reference

Toward improved immunocompetence of adoptively transferred CD8+ T cells

21 January 2018

1 reference

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion

21 January 2018

1 reference

Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies.

21 January 2018

1 reference

Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

21 January 2018

1 reference

Prospects for the use of NK cells in immunotherapy of human cancer.

21 January 2018

1 reference